Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
12/06/2006 | CN1872073A Drop pills of oleanolic acid, and preparation method |
12/06/2006 | CN1872070A Powder and injection preparation of left ofloxacin hydrochloric acid, and preparation method |
12/06/2006 | CN1872069A Injection of compound aminophylline for animal use, and preparation method |
12/06/2006 | CN1872067A Non-sedating barbiturate compounds as neuroprotective agents |
12/06/2006 | CN1872065A Capsules of gatifloxacin, and technique of dry process |
12/06/2006 | CN1872059A Drop pills of matrine, and preparation method |
12/06/2006 | CN1872057A Soluble compound medicinal preparation of antibacterial drugs, and preparation method |
12/06/2006 | CN1872056A Compound preparation of amoxicillin and bromhexine HCL suitable to application of children, prescription and preparation method |
12/06/2006 | CN1872055A Compound preparation of amoxicillin and ambroxol hydrochloride suitable to use for children, prescription and preparation method |
12/06/2006 | CN1872050A Drop pills of silymarin, and preparation method |
12/06/2006 | CN1872033A Enteric coated drop pills of garlicin, and preparation method |
12/06/2006 | CN1872026A New medicinal preparation for vagina |
12/06/2006 | CN1872020A Health care towel for health of feet |
12/06/2006 | CN1288156C Nianzhou Strain and its use |
12/06/2006 | CN1288153C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase |
12/06/2006 | CN1288152C 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same |
12/06/2006 | CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
12/06/2006 | CN1288134C Antibacterial mutilins |
12/06/2006 | CN1287858C Foot-and-mouth disease gene engineering polypeptide vaccine and its preparing method |
12/06/2006 | CN1287845C Antitubercular Chinese medicine |
12/06/2006 | CN1287830C Chinese traditional medicine compound preparation for treating gynecopathy and preparation method thereof |
12/06/2006 | CN1287828C Antivirus medicine and its preparing method |
12/06/2006 | CN1287825C Medicine for treating liver disease and its preparing process |
12/06/2006 | CN1287811C Lung clearing preparation for treating respiratory virus infection diseases |
12/06/2006 | CN1287803C Partial mouth composition for promoting whole body health and its application |
12/06/2006 | CN1287797C Gancilorvir dispersable tablet and its preparation |
12/06/2006 | CN1287793C Medicine having anti-infection and analgetic function |
12/06/2006 | CN1287776C Process for preparing houttuyninum sodium injection |
12/06/2006 | CN1287770C Pharmaceutical compositions in particulate form |
12/06/2006 | CA2549663A1 Endoribonuclease and uses thereof |
12/05/2006 | US7145002 Antibiotic product for therapy of infections |
12/05/2006 | US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents |
12/05/2006 | US7144893 4-aryl quinols and analogs thereof as therapeutic agents |
12/05/2006 | US7144879 Substituted metal-phthalocyanines, their preparation and the use thereof |
12/05/2006 | US7144873 Therapy for anticancer agents, blood disorders; dissolving in nonaqueous solvent |
12/05/2006 | US7144870 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits |
12/05/2006 | US7144855 Protein complex from ion-exchange chromatography for treatment of bacterial infections |
12/05/2006 | US7144698 Postweaning multisystemic wasting syndrome virus from pigs |
12/05/2006 | US7144578 Mixture of attenuated genetic engineered virus and carrier |
12/05/2006 | CA2434386C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
12/05/2006 | CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
12/05/2006 | CA2262840C Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals |
12/05/2006 | CA2246802C A human cytomegalovirus combined antigen and its use |
12/05/2006 | CA2159058C Inhibition of helicobacter |
12/05/2006 | CA2146429C 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
12/03/2006 | CA2547744A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
11/30/2006 | WO2009128043A1 Inactivated live-attenuated bluetongue virus vaccine |
11/30/2006 | WO2006128150A2 Crystalline solid forms of tigecycline and methods of preparing same |
11/30/2006 | WO2006127822A2 Scytovirin domain 1 related polypeptides |
11/30/2006 | WO2006127576A2 N - formyl hydroxylamine compounds as pdf inhibitors |
11/30/2006 | WO2006127539A1 Use of chalcones for the treatment of viral disorders |
11/30/2006 | WO2006127482A1 Methylene blue therapy of viral disease |
11/30/2006 | WO2006127217A2 Cyclopropanecarboxylate esters of acyclovir |
11/30/2006 | WO2006126719A1 Tlr activator and vaccine composition |
11/30/2006 | WO2006126675A1 Agent for external application to the skin |
11/30/2006 | WO2006126630A1 Method for preparation of aqueous doripenem solution |
11/30/2006 | WO2006126171A2 New antibiotic derivatives |
11/30/2006 | WO2006125974A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
11/30/2006 | WO2006125914A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
11/30/2006 | WO2006125807A1 Thiazole derivatives and use thereof |
11/30/2006 | WO2006125803A1 Thiazole derivatives and use thereof |
11/30/2006 | WO2006125318A1 Process for treating animal waste |
11/30/2006 | WO2006109898A8 Antimicrobial composition containing natural extract, nano silver and natural essential oil |
11/30/2006 | WO2006109323B1 Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives |
11/30/2006 | WO2006092741A3 Treatment of inflammatory disorders with praziquantel |
11/30/2006 | US20060270839 Crystallization of IGF-1 |
11/30/2006 | US20060270719 2-[(Cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-2-yl-benzyl)-amino]-N-hydroxy-acetamide; selective inhibitors of matrix-degrading metalloproteinases, especially MT1-MMP, MMP-2 and MMP-9; Osteoporosis; Antitumor, antiproliferative agents |
11/30/2006 | US20060270718 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
11/30/2006 | US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
11/30/2006 | US20060270681 Pyridazine derivatives |
11/30/2006 | US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
11/30/2006 | US20060270678 Pyrrolopyridazine derivatives |
11/30/2006 | US20060270676 Hydrazono-malonitriles |
11/30/2006 | US20060270651 Antibacterial agents |
11/30/2006 | US20060270649 Azetidine derivatives, their preparation and medicaments containing them |
11/30/2006 | US20060270637 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents |
11/30/2006 | US20060270636 Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds |
11/30/2006 | US20060270627 Synthetic oligomannosides, preparation and uses thereof |
11/30/2006 | US20060270624 Gapped 2' modified oligonucleotides |
11/30/2006 | US20060270009 Oxidation resistance; from hesperidin using Aspergillus fermentation |
11/30/2006 | US20060269954 Self-assembling recombinant papillomavirus capsid proteins |
11/30/2006 | US20060269953 Novel hepatitis B virus |
11/30/2006 | US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis |
11/30/2006 | US20060269562 Polypeptides f' of the hepatitis c virus, t epitopeo, and the diagnostic and therapeutic applications thereof |
11/30/2006 | US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
11/30/2006 | DE19781703B4 Gegen Tumoren wirksame Anthracyclindisaccharide, Fermentationsverfahren zu deren Herstellung und diese enthaltende therapeutische Zusammensetzung Effective against tumors Anthracyclindisaccharide, fermentation processes for their preparation and therapeutic composition containing them |
11/30/2006 | DE102005023666A1 Use of marmot oils for the treatment of skin diseases such as acne vulgaris, acne rosacea, neurodermitits, phlebitis, herpes or external hemorrhoids |
11/30/2006 | CA2609875A1 Crystalline solid forms of tigecycline and methods of preparing same |
11/30/2006 | CA2609356A1 Process for treating animal waste |
11/30/2006 | CA2609347A1 Use of chalcones for the treatment of viral disorders |
11/30/2006 | CA2608687A1 New antibiotic derivatives |
11/30/2006 | CA2608634A1 N-formyl hydroxylamine compounds as pdf inhibitors |
11/30/2006 | CA2608153A1 Thiazole derivatives for use as p13k modulators |
11/30/2006 | CA2608143A1 Thiazole derivatives and use thereof |
11/30/2006 | CA2608072A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
11/30/2006 | CA2545557A1 Stromal antigen-presenting cells and use thereof |
11/29/2006 | EP1726638A1 Novel lactic acid bacterium |
11/29/2006 | EP1725660A2 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
11/29/2006 | EP1725569A1 Prodrugs of piperazine and substituted piperidine antiviral agents |
11/29/2006 | EP1725556A1 Hiv integrase inhibitors |